Raw Material Status Control

Raw Material Status Control: Quarantine, Approved, and Rejected Workflows

Raw materials used in pharmaceutical manufacturing must be properly identified, evaluated, and released before they can enter production. Without a consistent method for communicating material status, manufacturers risk using materials that have not completed required testing or have been rejected for use.


Raw material status control establishes how materials are identified and managed as they move through receiving, inspection, testing, and disposition. Quarantine, Approved, and Rejected labels provide visible status information that helps warehouse, production, and Quality Control personnel distinguish materials at different stages of the process.


When integrated with documented procedures and accurate records, these labels support material traceability, inventory management, and compliance with applicable current Good Manufacturing Practice (cGMP) requirements.

What are you trying to accomplish right now?

I need to identify materials awaiting inspection or quality approval →

I need to mark materials that have passed inspection and are approved for use →

I need to identify rejected materials or products that cannot move forward →

I need labels that can be updated as materials move through different quality control stages →

What Is Raw Material Status Control in Manufacturing?

Raw material status control is the process of identifying, documenting, and managing the disposition of materials throughout manufacturing operations.


In pharmaceutical manufacturing, materials generally remain under quarantine until appropriate testing or examination has been completed and the Quality Control unit has authorized their release.


Under 21 CFR 211.80, manufacturers must establish written procedures covering the receipt, identification, storage, handling, sampling, testing, and approval or rejection of components and drug product containers and closures.


The regulation also requires each lot to be appropriately identified according to its status, including Quarantined, Approved, or Rejected.


Status identification provides employees with a consistent way to recognize material disposition. However, the label must reflect the authorized decision documented through the facility's quality system.
For an overview of the procedures supporting these activities, see our guide to cGMP Status Labeling Procedures: Best Practices for Compliance and Quality Control.

Understanding Quarantine, Approved, and Rejected Material Statuses

The three primary material status categories communicate whether a material is awaiting evaluation, released for use, or unsuitable for its intended manufacturing application.

Quarantine: Materials Awaiting Evaluation

Quarantine identifies materials that have not yet been released for manufacturing use.


Following receipt, materials are examined for appropriate identification, damaged containers, broken seals, and possible contamination. Under 21 CFR 211.82, components and drug product containers and closures must remain under quarantine until the required testing or examination and release activities are completed.


Quarantine labels help employees distinguish these materials from approved inventory.


Depending on facility procedures, quarantine controls may involve designated storage areas, restricted inventory access, electronic status restrictions, or a combination of methods.


A Quarantine label communicates that material use is restricted pending further evaluation. It does not independently establish or enforce the required controls.

Approved: Materials Released for Manufacturing

Approved status indicates that the Quality Control unit has authorized a material lot for use after the applicable review, testing, or examination requirements have been satisfied.


Under 21 CFR 211.84, material lots must be withheld from use until the appropriate activities are completed and the Quality Control unit releases them.


An Approved label helps production and warehouse personnel identify materials that have completed the required disposition process.


Before a status label is updated, the responsible personnel should verify that the release decision has been documented and the material identification matches the authorized records.


Approval also does not eliminate other handling requirements, such as storage conditions, expiration dating, or retesting controls where applicable.

Rejected: Materials Not Approved for Use

Rejected status identifies materials determined unsuitable for their intended manufacturing use.


Materials may be rejected after failing established specifications or other applicable quality requirements.


Under 21 CFR 211.89, rejected components and drug product containers and closures must be identified and controlled under a quarantine system designed to prevent their inappropriate use.


Rejected labels provide a clear visual warning to employees. However, additional controls may be necessary to prevent rejected materials from being issued to production.


These controls may include segregated storage, restricted inventory transactions, and documented disposition activities.

How Raw Material Status Changes Are Managed

Material status changes should follow a defined workflow that connects physical identification with authorized quality decisions.


A typical pharmaceutical raw material workflow includes the following steps:


1. Material receipt: Warehouse personnel receive and identify the material, inspect the shipment as required, and assign or associate the appropriate lot identification.


2. Quarantine identification: The material is placed under quarantine controls while required sampling, testing, examination, and review activities are performed.

3. Quality Control disposition: The Quality Control unit evaluates the applicable results and determines whether the material can be released or must be rejected.


4. Status identification update: Authorized personnel update the physical status identification to reflect the documented disposition decision.


5. Inventory management: Approved materials become eligible for use under applicable procedures, while rejected materials remain controlled to prevent unintended use.


At each stage, the physical label should remain consistent with the material's documented status.


If a discrepancy occurs between a label and the corresponding record, employees should follow established procedures to resolve the issue before proceeding.

Best Practices for Raw Material Status Labeling

Consistent raw material status identification requires clear procedures, appropriate labeling materials, and defined employee responsibilities.


Manufacturers should consider these practices when developing or reviewing material labeling workflows:


  • Standardize status terminology. Use consistent Quarantine, Approved, and Rejected designations across applicable departments.
  • Include identifying information. Material names, lot numbers, internal identifiers, and applicable status information help connect labels to the correct inventory.

  • Define authorization responsibilities. Establish who may change physical status identification after Quality Control disposition.

  • Use legible and durable labels. Select materials that remain readable under expected storage, handling, and environmental conditions.

  • Prevent conflicting identification. Remove or appropriately supersede outdated labels when material status changes.

  • Maintain record consistency. Verify that physical labels correspond with applicable inventory and quality management records.

Manufacturers may use color-coded QC status labels to make different categories easier to recognize. However, color alone should not replace written status information or established identification controls.

Common Raw Material Status Control Challenges

Even established material management processes can experience identification problems.


Common challenges include missing or damaged labels, unclear lot references, outdated quarantine identification, and inconsistencies between physical materials and electronic inventory records.


Another concern is updating a status label before the required release or rejection decision has been authorized.


These situations can create uncertainty for personnel responsible for material handling and production preparation.


Regular procedural reviews, employee training, and appropriate verification practices help manufacturers identify and address these gaps.


Facilities should also evaluate whether the labeling materials selected for their operations remain readable and securely associated with the intended containers during storage and handling.

Supporting cGMP Labeling Procedures with Reliable Identification Solutions

Clear material status communication is an important part of maintaining organized and controlled manufacturing operations.


Since 1987, GMP Labeling has provided compliance identification and quality control labeling solutions for FDA-regulated industries.


Our Quarantine, Approved, Rejected, and custom QC label options help manufacturers communicate material disposition throughout receiving, storage, and production workflows.


Whether standardizing existing material identification formats or selecting labels for specific operating conditions, GMP Labeling provides solutions that support documented status control procedures.


Reach out to a specialist to learn more today!

Have More Questions?

Explore our Frequently Asked Questions for answers to common questions, helpful insights, and additional guidance on this topic.

Related Products

Quarantine Status Labels
Clearly identify materials awaiting inspection, testing, or disposition. Available with fields for recording lot numbers, quantities, dates, and responsible personnel.

Approved and Accepted Labels

Identify materials and products that have passed inspection and are cleared for their designated next step in the manufacturing or distribution process.

Rejected Status Labels

Make nonconforming materials and products easy to identify so they can be segregated and directed toward the appropriate disposition process.